Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer

BJU International

Volumn 100, Issue 2, 2007, Pages 303-309

  Koumakpayi, Ismaël H ^a   Diallo, Jean Simon ^a   Le Page, Cécile ^a   Lessard, Laurent ^a   Filali Mouhim, Abdelali ^a   Bégin, Louis R ^a,b   Mes Masson, Anne Marie ^a   Saad, Fred ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

Biochemical recurrence; Nuclear ErbB3; Positive surgical margins; Prostate cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CELL MEMBRANE; DISEASE COURSE; FOLLOW UP; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UNIVARIATE ANALYSIS;

EID: 34447119748     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06992.x     Document Type: Article

References (33)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005 55 : 10 30
2. Freedland SJ, Humphreys EB, Mangold LA et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005 294 : 433 9
3. Winkler MH, Khan FA, Shabir M et al. Contemporary update of cancer control after radical prostatectomy in the UK. Br J Cancer 2004 91 : 1853 7
4. Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA. Biochemical failure in men following radical retropubic prostatectomy. impact of surgical margin status and location. J Urol 2004 172 : 129 32
5. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001 2 : 127 37
6. Poller DN, Spendlove I, Baker C et al. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. J Pathol 1992 168 : 275 80
7. Lo HW, Hung MC. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 2006 94 : 184 8
8. Lin SY, Makino K, Xia W et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001 3 : 802 8
9. Xie Y, Hung MC. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem Biophys Res Commun 1994 203 : 1589 98
10. Wang SC, Lien HC, Xia W et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004 6 : 251 61
11. Lo HW, Xia W, Wei Y, Ali-Seyed M, Huang SF, Hung MC. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005 65 : 338 48
12. Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2005 95 : 211 8
13. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW. c-erbB-3: a nuclear protein in mammary epithelial cells. J Cell Biol 2002 157 : 929 39
14. Srinivasan R, Gillett CE, Barnes DM, Gullick WJ. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res 2000 60 : 1483 7
15. Edwards J, Traynor P, Munro AF, Pirret CF, Dunne B, Bartlett JM. The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer. Clin Cancer Res 2006 12 : 123 30
16. Koumakpayi IH, Diallo JS, Le Page C et al. Expression and Nuclear Localization of ErbB3 in Prostate Cancer. Clin Cancer Res 2006 12 : 2730 7
17. Vakar-Lopez F, Cheng CJ, Kim J et al. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol 2004 203 : 688 95
18. Myers RB, Srivastava S, Oelschlager DK, Grizzle WE. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst 1994 86 : 1140 5
19. Hernes E, Fossa SD, Berner A, Otnes B, Nesland JM. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer 2004 90 : 449 54
20. Leung HY, Weston J, Gullick WJ, Williams G. A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma. Br J Urol 1997 79 : 212 6
21. Rajkumar T, Gullick WJ. A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines. Br J Cancer 1994 70 : 459 65
22. Cohen BD, Kiener PA, Green JM, Foy L, Fell HP, Zhang K. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem 1996 271 : 30897 903
23. Shuford MD, Cookson MS, Chang SS et al. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy. J Urol 2004 172 : 119 23
24. Freedland SJ, Aronson WJ, Presti JC et al. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer 2004 100 : 1633 8
25. Okotie OT, Aronson WJ, Wieder JA et al. Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. J Urol 2004 171 : 2260 4
26. Pawlowski V, Revillion F, Hebbar M, Hornez L, Peyrat JP. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000 6 : 4217 25
27. Travis A, Pinder SE, Robertson JF et al. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Br J Cancer 1996 74 : 229 33
28. Lyne JC, Melhem MF, Finley GG et al. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Cancer J Sci Am 1997 3 : 21 30
29. Psyrri A, Kassar M, Yu Z et al. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin Cancer Res 2005 11 : 8637 43
30. Lo HW, Hsu SC, Ali-Seyed M et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005 7 : 575 89
31. Williams CC, Allison JG, Vidal GA et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 2004 167 : 469 78
32. Zhang Y, Wang XW, Jelovac D et al. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci USA 2005 102 : 9890 5
33. Zhang Y, Hamburger AW. Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling. Br J Cancer 2005 92 : 140 6